Jan B. Vermorken

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Jan B. Vermorken, Fernando Rivera, Éva Remenár et al. · New England Journal of Medicine · 2008 · 3.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy

Jan B. Vermorken, José Trigo, Ricardo Hitt et al. · Journal of Clinical Oncology · 2007 · 1K citations · Full text

Medicine, Oncology, Pharmacology +16

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen et al. · Annals of Oncology · 1994 · 259 citations

Medicine, Oncology, Pharmacology +7

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

J. Bernier, James A. Bonner, Jan B. Vermorken et al. · Annals of Oncology · 2007 · 218 citations · Full text

Medicine, Dermatology, Oncology +16

Long-term survival in ovarian cancer

J.P. Neijt, W.W. ten Bokkel Huinink, M.E.L. van der Burg et al. · European Journal of Cancer and Clinical Oncology · 1991 · 213 citations

Medicine, Oncology, Surgery +14